Tuba City Regional Health Selects Allscripts Sunrise(TM)
Jan 20, 2016 13:01 pm UTC| Business
CHICAGO, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Tuba City Regional Health Care Corporation (TCRHCC) of Arizona selected the Allscripts Sunrise and Allscripts Care Director™ solutions to provide an integrated electronic health...
UBIC, Inc. to Announce Third Quarter Ended December 31, 2015 Financial Results
Jan 20, 2016 13:00 pm UTC| Business
NEW YORK, Jan. 20, 2016 (GLOBE NEWSWIRE) -- UBIC, Inc. (NASDAQ:UBIC) (TSE:2158) (“UBIC” or “the Company”), a leading provider of international litigation support and big-data analysis services, today announced that the...
Silicon Motion Announces Quarterly Dividend
Jan 20, 2016 13:00 pm UTC| Business
TAIPEI, Taiwan, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or the “Company”), a global leader in NAND flash controllers for solid state storage devices and...
CytomX Announces Third Target Selection by Bristol-Myers Squibb, Triggering Milestone
Jan 20, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2016 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today...
Square 1 Bank Announces Credit Facility to PlayMaker CRM, Inc.
Jan 20, 2016 13:00 pm UTC| Business
DURHAM, N.C., Jan. 20, 2016 (GLOBE NEWSWIRE) -- Square 1 Bank, a division of Pacific Western Bank, today announced that it has provided a $3 million credit facility to new client, PlayMaker CRM, Inc., a leading customer...
Sprott Announces Preliminary 2015 Year End Assets Under Management
Jan 20, 2016 13:00 pm UTC| Business
TORONTO, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Sprott Inc. (TSX:SII) ("Sprott" or the "Company") today announced its preliminary estimate of Assets Under Management (“AUM”) and Performance Fees for the year ended December...
Jan 20, 2016 13:00 pm UTC| Business
NEWARK, Calif., Jan. 20, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today...